"The widespread use of human papilloma virus vaccines, promoted by the manufacturers in a public advertising campaign, is about to add costs to an already strained cancer prevention budget while the effectiveness of vaccinations cannot be evaluated for two or three decades, the daily paper Dagens Nyheter reports."